Track the ACCURAY INCORPORATED share price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €32.7m. The latest transaction was filed on 12 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: LEONEL PERALTA. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
ACCURAY INCORPORATED es una empresa centrada en el desarrollo de sistemas de radioterapia para el tratamiento del cáncer. Cotiza en el mercado XNAS.